Literature DB >> 10665788

Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.

V Rudat1, A Dietz, O Schramm, C Conradt, H Maier, M Flentje, M Wannenmacher.   

Abstract

PURPOSE: To identify prognostic clinical and treatment related factors for local control, distant metastasis-free survival, and survival by means of a multivariate analysis in patients with advanced squamous cell carcinoma of the head and neck after concomitant boost radiochemotherapy. PATIENTS AND METHODS: From 1992 to 1995, 68 patients with squamous cell cancer of the head and neck (93% stage IV disease) were treated with a simultaneous radiochemotherapy with Carboplatin using a concomitant boost technique. The total tumor volume (TTV) was quantitatively determined based on computed tomography scans in 56 patients. A Cox proportional hazards regression analysis was performed for each of the above endpoints and statistical significance of the Cox models was verified using the likelihood ratio test and Bonferroni correction for multiple testing.
RESULTS: The survival and locoregional control rates at three years were 35 and 32%. The multivariate analysis revealed a significant association between the TTV and survival (P = 0.0008) and between the pretreatment serum hemoglobin concentration and locoregional control (P = 0.01) and survival (P = 0.05). The locoregional control was significantly associated with the N-stage (P = 0.007) and there was a good correlation between the N-stage and TTV in this study population.
CONCLUSION: Our data corroborate the prognostic relevance of the tumor volume and hemoglobin concentration. In studies comparing the survival of patients with advanced cancer of the head and neck, the use of the TTV as a covariable may improve the statistical power.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10665788     DOI: 10.1016/s0167-8140(99)00119-x

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  14 in total

Review 1.  [The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].

Authors:  K Heine; J M Wolff
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

2.  Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer.

Authors:  Ming-Huang Chen; Peter Mu-Hsin Chang; Po-Min Chen; Cheng-Hwai Tzeng; Pen-Yuan Chu; Shyue-Yih Chang; Muh-Hwa Yang
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-24       Impact factor: 4.553

3.  An outcome of Surgically Treated Head and Neck Cancer in one of the tertiary Referral Center in the East Coast of Malaysia: A 6-year Retrospective Analysis.

Authors:  Kahairi Abdullah; Raja Ahmad Raja Lope Ahmad; Zamzil Amin Asha'ari; Mohd Sayuti Razali; Wan Islah Leman
Journal:  Malays J Med Sci       Date:  2014-07

Review 4.  Treatment resistance of solid tumors: role of hypoxia and anemia.

Authors:  P Vaupel; O Thews; M Hoeckel
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

5.  Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.

Authors:  Amita Shukla-Dave; Nancy Y Lee; Jacobus F A Jansen; Howard T Thaler; Hilda E Stambuk; Matthew G Fury; Snehal G Patel; Andre L Moreira; Eric Sherman; Sasan Karimi; Ya Wang; Dennis Kraus; Jatin P Shah; David G Pfister; Jason A Koutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-19       Impact factor: 7.038

6.  Impact of initial tumor volume on radiotherapy outcome in patients with T2 glottic cancer.

Authors:  T Rutkowski
Journal:  Strahlenther Onkol       Date:  2014-03-04       Impact factor: 3.621

7.  Comparing primary tumors and metastatic nodes in head and neck cancer using intravoxel incoherent motion imaging: a preliminary experience.

Authors:  Yonggang Lu; Jacobus F A Jansen; Hilda E Stambuk; Gaorav Gupta; Nancy Lee; Mithat Gonen; Andre Moreira; Yousef Mazaheri; Snehal G Patel; Joseph O Deasy; Jatin P Shah; Amita Shukla-Dave
Journal:  J Comput Assist Tomogr       Date:  2013 May-Jun       Impact factor: 1.826

8.  Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx.

Authors:  Andrew R Gordon; Laurie A Loevner; Amita Shukla-Dave; Regina O Redfern; Adina I Sonners; Alex M Kilger; Mark A Elliott; Mitchell Machtay; Randal S Weber; Jerry D Glickson; David I Rosenthal
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

9.  Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy.

Authors:  Cem Parlak; Erkan Topkan; Cem Onal; Mehmet Reyhan; Ugur Selek
Journal:  Radiat Oncol       Date:  2012-03-19       Impact factor: 3.481

10.  Volumetric and MGMT parameters in glioblastoma patients: survival analysis.

Authors:  Georgios Iliadis; Vassiliki Kotoula; Athanasios Chatzisotiriou; Despina Televantou; Anastasia G Eleftheraki; Sofia Lambaki; Despina Misailidou; Panagiotis Selviaridis; George Fountzilas
Journal:  BMC Cancer       Date:  2012-01-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.